Information Provided By: 
Fly News Breaks for April 26, 2019
ZBH
Apr 26, 2019 | 12:55 EDT
Piper Jaffray analyst Matt O'Brien said Zimmer Biomet reported Q1 results that were "slightly ahead" of his estimates and the consensus view, adding that he believe the higher end of the company's reiterated full year guidance is achievable, particularly in terms of revenue. With that said, he still thinks the company's growth profile "is not that compelling at this point" and he recommends waiting for evidence of strong demand for its new robotic systems before turning more constructive. O'Brien keeps a Neutral rating on Zimmer Biomet shares.
News For ZBH From the Last 2 Days
There are no results for your query ZBH
